Legal Status of Trenbolone Enanthate in Ukraine and the EU

The legal status of trenbolone enanthate is often described simplistically: 'legal', 'banned', 'borderline'. In reality the answer consists of several levels — legislation on medicines, veterinary regulation, anti-doping rules and the criminal law of individual countries. The editorial team explains the general logic of these levels for Ukraine and the EU. This material is not legal advice: legislation changes, and a specialist is needed for a specific situation.

Trenbolone enanthate as an 'unregistered agent'

The first step in any legal analysis is the question of registration. Trenbolone enanthate is not registered as a medicine for humans either in Ukraine or in any EU country. It is also not a veterinary drug: in the animal husbandry of some countries outside the EU a different ester is used — trenbolone acetate in the form of implants.

So a product called 'trenbolone enanthate' by definition cannot be legally sold as a medicine. It has no marketing authorization, no instructions approved by a regulator, and no manufacturer answerable to the state for quality. This distinguishes it from, for example, testosterone, which is a prescription medicine.

The only form of trenbolone that once had the status of a human medicine — trenbolone hexahydrobenzylcarbonate (Parabolan, France). Its production ceased in the late 1990s, and today it is not registered in the EU either.

The absence of registration does not mean automatic criminal liability for any actions with the drug. The consequences depend on what exactly a person does (manufactures, sells, imports, stores or uses) and on the legislation of the specific country. This is precisely where substantial differences begin.

Ukraine: what regulates circulation

The basic act is the Law of Ukraine 'On Medicinal Products', under which medicines are admitted to circulation after state registration. Manufacture, wholesale and retail trade in medicines require a license. The sale of unregistered agents violates these requirements and entails administrative or other liability depending on the circumstances.

The Criminal Code of Ukraine contains Article 321-1 on the falsification of medicines and the circulation of falsified medicines. Ukraine is also a party to the Council of Europe MEDICRIME Convention aimed at combating the counterfeiting of medical products. For black-market steroid products the issue of falsification is highly relevant.

Separately, the Criminal Code provides for liability for inducing minors to use doping. This reflects the state's position on the special vulnerability of youth.

The status of anabolic steroids in the list of controlled substances (the List of Narcotic Drugs, Psychotropic Substances and Precursors, approved by Cabinet of Ministers Resolution No. 770) should be checked in the current edition of the document, since changes are made regularly. The editorial team recommends turning to official sources rather than to forums, where information is often outdated.

The European Union: common rules and national laws

At the EU level there are common rules on medicines. Directive 2001/83/EC establishes that a medicinal product may be placed on the market only after obtaining authorization. Directive 2011/62/EC strengthened measures against falsified medicines, in particular in supply chains.

In the veterinary sphere, the EU has since the late 1980s banned the use of hormonal substances to promote growth in farm animals. The current Directive 96/22/EC covers trenbolone. Associated with this is the long-running dispute of the EU with the USA and Canada at the WTO over the import of beef from animals given hormones.

Criminal regulation of doping outside sport remains a matter for individual states, and approaches vary greatly. Sweden has a special law banning certain doping agents, which criminalizes not only circulation but also use. Since 2015 Germany has had an Anti-Doping Act (Anti-Doping-Gesetz), which prohibits, in particular, the circulation of doping agents as well as their acquisition and storage in quantities exceeding an established threshold (a 'not insignificant quantity') for the purpose of doping. Italy introduced criminal liability for doping by Law No. 376 of 2000.

In other EU countries the main focus is on manufacture, trade and importation, whereas storage for personal use may not be a crime. However, customs rules on the importation of unregistered medicines apply in all countries, and parcels with drugs are often seized.

Sport: WADA rules regardless of country

For athletes subject to anti-doping rules, the question is resolved unambiguously. Trenbolone is included in section S1 'Anabolic Agents' of the WADA Prohibited List and is banned at all times — both in competition and out of competition.

Anti-doping rules apply regardless of a country's criminal law. Even where storing the drug for personal use is not a crime, the detection of trenbolone or its metabolites in an athlete's sample is a violation of the anti-doping rules with a corresponding disqualification.

Ukraine is a party to the UNESCO International Convention against Doping in Sport and the Council of Europe Anti-Doping Convention. The national anti-doping organization implements the World Anti-Doping Code into the national system.

Importantly, liability in sport is based on the principle of strict liability: an athlete is responsible for any prohibited substance in their body, regardless of intent. This also applies to cases where the substance entered through a contaminated food supplement.

Practical consequences for a person

Even where use is not criminalized, a person faces a number of legal and practical risks. They should be assessed soberly rather than relying on advice from unofficial sources.

• Lack of consumer protection.The buyer cannot demand conformity of composition or compensation for harm.
• Customs risks.Parcels with unregistered agents may be seized, and the sender and recipient may be held liable.
• Professional consequences.For athletes, military personnel and workers in certain professions, detection of the substance may have disciplinary consequences.
• Liability for transfer to others.Selling or transferring the drug, especially to minors, substantially increases the level of liability.

Seeking medical help regarding the consequences of AAS use creates no legal risks for the patient: medical information is protected by medical confidentiality. Fear of the law should not be a reason to delay medical care.

Since legislation is constantly changing, the editorial team recommends checking the current editions of legal acts on official portals and, if necessary, consulting a lawyer.

Editorial conclusions

Trenbolone enanthate is not registered as a medicinal or veterinary agent either in Ukraine or in the EU, so its legal sale as a medicine is impossible.

Criminal liability for actions involving the drug depends on the country and type of activity: some EU states punish even use, others focus on circulation.

In sport the question is resolved unambiguously: trenbolone is banned by WADA at all times, regardless of national legislation.

We also recommend reading 'How to Recognize a Counterfeit Trenbolone Enanthate', 'Metabolites of Trenbolone Enanthate: How the Body Breaks Down the Drug' and 'Recovery of the Body After Using Trenbolone Enanthate'.

References

1. World Anti-Doping Agency. The World Anti-Doping Code International Standard: Prohibited List. Montreal: WADA; чинна редакція.
2. Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use. OJ L 311, 28.11.2001.
3. Directive 2011/62/EU of the European Parliament and of the Council of 8 June 2011 amending Directive 2001/83/EC as regards the prevention of the entry into the legal supply chain of falsified medicinal products. OJ L 174, 1.7.2011.
4. Council Directive 96/22/EC of 29 April 1996 concerning the prohibition on the use in stockfarming of certain substances having a hormonal or thyrostatic action and of β-agonists. OJ L 125, 23.5.1996.
5. Council of Europe. Convention on the counterfeiting of medical products and similar crimes involving threats to public health (MEDICRIME Convention). CETS No. 211. Moscow; 2011.
6. UNESCO. International Convention against Doping in Sport. Paris; 2005.
7. Закон України «Про лікарські засоби» від 04.04.1996 № 123/96-ВР (чинна редакція).